Desired Vancomycin Trough Serum Concentration for Treating Invasive Methicillin-resistant Staphylococcal Infections

被引：103

作者：

Frymoyer, Adam ^{[1
]}

Guglielmo, B. Joseph ^{[2
]}

Hersh, Adam L. ^{[3
]}

机构：

[1] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA

[2] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA

[3] Univ Utah, Dept Pediat, Salt Lake City, UT USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2013年 / 32卷 / 10期

关键词：

vancomycin; children; pharmacokinetics; methicillin-resistant Staphylococcus aureus; PEDIATRIC-PATIENTS; AUREUS INFECTIONS; DISEASES SOCIETY; CHILDREN; PHARMACODYNAMICS; PHARMACOKINETICS; NEPHROTOXICITY; GUIDELINES; AMERICA;

D O I：

10.1097/INF.0b013e318299f75c

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Vancomycin area under the curve/minimal inhibitory concentration (AUC/MIC) >400 best predicts the outcome when treating invasive methicillin-resistant Staphylococcus aureus infection; however, trough serum concentrations are used clinically to assess the appropriateness of dosing. We used pharmacokinetic modeling and simulation to examine the relationship between vancomycin trough values and AUC/MIC in children receiving vancomycin 15mg/kg every 6 hours and methicillin-resistant Staphylococcus aureus MIC of 1 g/mL. A trough of 7-10 g/mL predicted achievement of AUC/MIC >400 in >90% of children.

引用

收藏

页码：1077 / 1079

页数：3

相关论文

共 15 条

[1] INFLUENCE OF MALIGNANCY ON THE PHARMACOKINETICS OF VANCOMYCIN IN INFANTS AND CHILDREN [J].

CHANG, D .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (08) :667-673

[2]

Chhim RF, 2012, J PED INFECT DIS

[3] Assessment of Vancomycin Dosing and Subsequent Serum Concentrations in Pediatric Patients [J].

Eiland, Lea S. ;

English, Thomas M. ;

Eiland, Edward H., III .

ANNALS OF PHARMACOTHERAPY, 2011, 45 (05) :582-589

[4] Impact of a Hospitalwide Increase in Empiric Pediatric Vancomycin Dosing on Initial Trough Concentrations [J].

Frymoyer, Adam ;

Guglielmo, B. Joseph ;

Wilson, Stephen D. ;

Scarpace, Sarah B. ;

Benet, Leslie Z. ;

Hersh, Adam L. .

PHARMACOTHERAPY, 2011, 31 (09) :871-876

[5] Prediction of Vancomycin Pharmacodynamics in Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections: A Monte Carlo Simulation [J].

Frymoyer, Adam ;

Hersh, Adam L. ;

Coralic, Zlatan ;

Benet, Leslie Z. ;

Guglielmo, B. Joseph .

CLINICAL THERAPEUTICS, 2010, 32 (03) :534-542

[6] Current Recommended Dosing of Vancomycin for Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections Is Inadequate [J].

Frymoyer, Adam ;

Hersh, Adam L. ;

Benet, Leslie Z. ;

Guglielmo, B. Joseph .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (05) :398-402

[7] Trends in the Incidence of Methicillin-Resistant Staphylococcus aureus Infection in Children's Hospitals in the United States [J].

Gerber, Jeffrey S. ;

Coffin, Susan E. ;

Smathers, Sarah A. ;

Zaoutis, Theoklis E. .

CLINICAL INFECTIOUS DISEASES, 2009, 49 (01) :65-71

[8] Trough Concentrations of Vancomycin Adult Therapeutic Targets Are Not Appropriate for Children [J].

Gordon, Claire L. ;

Thompson, Chantelle ;

Carapetis, Jonathan R. ;

Turnidge, John ;

Kilburn, Charles ;

Currie, Bart J. .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (12) :1269-1271

[9] A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population [J].

Lamarre, P ;

Lebel, D ;

Ducharme, MP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :278-282

[10]

Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI [10.1093/cid/cir034, 10.1093/cid/ciq146]